Advertisement

Topics

Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG Company Profile

02:00 EDT 18th October 2017 | BioPortfolio


News Articles [2069 Associated News Articles listed on BioPortfolio]

Novartis: Dividendengarant mit Produktoffensive

Die Meldungen reißen derzeit beim Schweizer Pharmakonzern Novartis nicht ab. Zuletzt hat Novartis vielversprechende Studiendaten zu seinem Produktkandidaten AMG 334 (Erenumab) zur Behandlung von Mi.....

Novartis: Neue Impulse

Die Analysten von Kepler Cheuvreux bleiben bei der Kaufempfehlung für die Aktien von Novartis. Verändert wird hingegen das Kursziel für die Schweizer Aktie. Bisher lag dieses für die Novartis-Papi...

Novartis: Deal-making and the Increasing Attraction of Venture Funds

In this episode of PharmaTelevision News Review, Fintan Walton talks with Tony Rosenberg, Global Head of Business Development at Novartis. Filmed at the PharmaTelevision Studios in Oxford, England, th...

Press Release: Novartis presents data -2-

Press Release: Novartis presents data demonstrating efficacy of AMG 334 (erenumab) in migraine prevention at the American Headache Society Annual Meeting Novartis International AG / Novartis prese...

Novartis appoints Bertrand Bodson as Chief Digital Officer

Novartis announced today that Bertrand Bodson, Chief Digital and Marketing Officer for Sainsbury's Argos, has been appointed to the new role of Chief Digital Officer, reporting to Joseph Jimenez, CEO ...

FDA to review Novartis CAR-T next month

FDA advisers will meet in July to begin their review of Novartis' CAR-T therapy tisagenlecleucel-T (CTL 109). This will make the drug the first CAR-T candidate to be scrutinised by the FDA’s ...

Jimenez to Quit Novartis Next Year

Novartis CEO Joseph Jimenez has announced he will leave the Swiss-based drugnaker in early 2018, after eight years at the helm, and return to his native US. However, he will remain "available for...

Novartis eye drug works with fewer injections than rival

ZURICH (Reuters) - A Novartis drug to treat a leading cause of vision loss in people over 65 does not need to be injected as frequently as a rival medicine from Regeneron Pharmaceuticals to be effecti...

PubMed Articles [140 Associated PubMed Articles listed on BioPortfolio]

Google, Novartis back Medicxi's ambitions.

Novartis snaps up Selexys for sickle cell.

First approval in sight for Novartis' CAR-T therapy after panel vote.

Novartis trial validates inflammasome as chronic disease driver.

Letter--The Authors Respond.

None of the authors of this study are involved in financial or personal relationships with agencies, institutions, or organizations that inappropriately influenced the statistical analysis plan or int...

Clinical Trials [281 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative

Countries throughout the world are facing a growing non-communicable disease (NCD) burden. In developing countries, medicines to treat NCDs are often difficult to access or too expensive f...

Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5mL Under Fed Condition

The purpose of this study is to compare the single-dose oral bioavailability of oxcarbazepine 300 mg/5mL oral suspension of OHM Laboratories, USA (a subsidiary of Ranbaxy Pharmaceuticals I...

Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5 mL Under Fasting Conditions

The study was conducted as an open label, balanced, randomized, two-treatment, two-period, two-sequence, single- dose, crossover bioavailability study comparing oxcarbazepine 300 mg/5mL or...

Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subject (Aged 6 to 72 Months) Versus Control Vaccines

This study will evaluate the safety, tolerability and immunogenicity of one or two 0.25mL or 0.5mL intramuscular injections of influenza vaccine compared with control vaccine in subjects 6...

Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety Study

The primary objective of this observational, comparative safety study is to evaluate the safety of the Novartis Pandemic Influenza A (H1N1) vaccine in pregnant women and their off spring, ...

Companies [2306 Associated Companies listed on BioPortfolio]

Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG

Novartis Consumer Health

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innova...

Novartis AG

Novartis's name, derived from the Latin novae artes, means "new skills" and reflects Novartis's commitment to focus research and development to bring new healthcare products to the...

Novartis Vaccines and Diagnostics

Novartis Vaccines is a global leader in providing vaccines to protect against deadly meningococcal disease. Through industry-leading scientific expertise, the company is focused on extending critical ...

Idenix Pharmaceuticals

Idenix is pursuing a disciplined business strategy that seeks to capitalize upon the diverse expertise of the company’s management team. While Idenix is focused on bringing its late-stage product ca...

More Information about "Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG" on BioPortfolio

We have published hundreds of Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG news stories on BioPortfolio along with dozens of Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG Clinical Trials and PubMed Articles about Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG Companies in our database. You can also find out about relevant Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record